Thermal Energy Secures $2.8M Deal for Pharma Carbon Reduction
Thermal Energy's $2.8M project with pharma giant cuts CO2 by 728 tons, boosting boiler efficiency.
Thermal Energy International Inc. has announced a $2.8 million project with a leading global pharmaceutical company to implement energy efficiency and carbon reduction solutions. This marks the third collaboration between the two organizations in just 15 months, reflecting a strong partnership aimed at achieving the customer’s 2030 emissions goals.
The project includes a HeatSponge® and FLU-ACE® heat recovery system integrated with a heat pump, expected to deliver 93% boiler efficiency. It is anticipated to reduce natural gas consumption and cut CO2 emissions by 728 tons annually, representing an 11% reduction for the site.
Thermal Energy’s CEO, William Crossland, expressed enthusiasm about the ongoing partnership, citing the significant opportunity to support the company’s sustainability goals across its 40 identified sites. The project is expected to be completed within 12 months, with revenue recognized in that timeframe.
Reporting on the science, business and regulation shaping the pharmaceutical industry.
Altro da Pharma News
Tutti gli articoli →
Medicus Pharma presenta all’FDA il protocollo di fase 2b/3 per Teverelix
Fresenius Kabi Riceve una Lettera di Richiamo dalla FDA dopo Fallimenti nelle Indagini sul Processo Asettico presso lo Stabilimento di Melrose Park
Discussion